Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04392635 · ClinicalTrials.gov registry record · NA
Device to Assist With Abdominal Access During Laparoscopic Surgery
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT04392635: Completed NA study, sponsored by Stanford University.
NCT04392635 is a NA study that has completed, run by Stanford University. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04392635, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and ease of use of a TauTona Pneumoperitoneum Assist Device (TPAD) to assist with obtaining peritoneal access with a Veress needle, and for placing a primary trocar, during laparoscopic surgery.
Interventions
- PROCEDURE Standard of Care (SOC)
- DEVICE TauTona Pneumoperitoneum Assist Device (TPAD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-06-20 |
| Est. Completion | 2024-06-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04392635
The ClinicalTrials.gov registry entry for NCT04392635 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care (SOC) is the first listed.
NCT04392635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04392635 about?
NCT04392635 is a clinical study titled "Device to Assist With Abdominal Access During Laparoscopic Surgery". The purpose of this study is to assess the safety and ease of use of a TauTona Pneumoperitoneum Assist Device (TPAD) to assist with obtaining peritoneal access with a Veress needle, and for placing a primary trocar, during laparoscopic surgery.
What is the current status of trial NCT04392635?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2022-06-20. Estimated completion is 2024-06-17.
What interventions are being tested in trial NCT04392635?
The interventions under investigation include: Standard of Care (SOC) (PROCEDURE), TauTona Pneumoperitoneum Assist Device (TPAD) (DEVICE).
Who is sponsoring clinical trial NCT04392635?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.